March 5, 2020 / 10:28 PM / a month ago

BRIEF-Eloxx Pharmaceuticals Reports Q4 Loss Per Share $0.29

March 5 (Reuters) - Eloxx Pharmaceuticals Inc:

* ELOXX PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.29

* Q4 EARNINGS PER SHARE ESTIMATE $-0.33 — REFINITIV IBES DATA

* TOPLINE DATA FROM PHASE 2 CYSTIC FIBROSIS CLINICAL TRIALS FOR ELX-02 IN H1 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below